KSM-66 Ashwagandha 300 mg for improving skin hydration, elasticity, and hair strength

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized, double-blind, placebo-controlled trial will enroll healthy men and women aged 18–60 with mild to moderate hair loss and randomize them to receive either a 300 mg KSM-66 Ashwagandha capsule or placebo for the study duration. Outcomes include validated questionnaires, dermatological examinations, and instrumental measurements of skin hydration, elasticity, barrier function, and hair density/strength such as Trichoscan. Participants must maintain consistent dietary, hair, and skin product routines and avoid other medications or supplements to limit confounding. The study tests whether Ashwagandha's adaptogenic, stress-modulating effects lead to measurable improvements in skin and hair health.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Healthy adult men and women participants ≥ 18 years and ≤60 years of age.
2. Willingness to follow the protocol requirements as evidenced by written informed consent.
3. Participants who were on consistent dietary, hair, and skin product 3 months prior to start of the study and are willing to follow the same during the study.
4. Participants who agree not to use any medication (prescription and over the counter), including vitamins and minerals, during or before the course of this study.
5. Participants with mild to moderate hair loss classified as the Norwood-Hamilton type II, III, IV and V in males and Ludwig type I and II in females.
6. Willing to come for all follow-up visits.
7. Participants who agree not to cut hair for the entire duration of the study.
8. Participants willing to undergo Trichoscan evaluation and not to wash their hair 48 hours before the visit.
9. Participants or LAR can and willing to give meaningful, written informed consent prior to participation in the trial, in accordance with regulatory requirements.
10. Participants who agree to take investigational product (i.e., Till Day 90 ± 4 ± 4).

Exclusion Criteria:

1. Participants having any clinically significant medical history, medical finding including rosacea, eczema, psoriasis, and atopic dermatitis or an on-going medical or psychiatric condition exists which in the opinion of the Investigator could jeopardize the safety of the subject, impact validity of the study results or interfere with the completion of study according to the protocol.
2. Participants on any medication or supplement for hair loss, including finasteride, any other 5 α-reductase inhibitor, minoxidil, steroids, or hormonal products, during the 3 months prior to study commencement.
3. Participants having a history of hypersensitivity reactions (i.e., allergic or oversensitivity to study medication).
4. Participants who have undergone or plan to undergo hair transplantation surgery during the study period.
5. Participants with facial skin cancer.
6. Participants with sunburn, moderate to pronounced suntan, uneven skin tones, tattoos, scars or other disfiguration, dilated vessels or other conditions on the test area that might influence the test results.
7. Participants with severe seborrheic dermatitis, alopecic disease, except for androgenic alopecia, and scalp disorders, such as scalp psoriasis and infection.
8. Participants who have participated in a clinical study during the preceding 180 days.
9. Participants having eating disorders (i.e., bulimia, psychogenic eating disorders, etc.).
10. Pregnant and lactating females
11. Participants with alcohol addiction or persistent abuse of drugs of dependence.

Where it's running

• San Francisco Research Institute
  San Francisco, California, United States Recruiting

Study contacts

• Study coordinator: Dr. John Ademola
• Email: jademola@sfinstitute.com
• Phone: 415-845-4638

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Nutraceutical supplement for hair growth in midlife women

  A 6-month, randomized, placebo-controlled test to see if a nutraceutical gel helps hair growth in premenopausal and menopausal women.

  Recruiting LycoRed Ltd. · Nice · NCT07880041

• Hyaluronic Acid Injections for Skin Health in Healthy Adults

  This study tests whether an HA-based injectable affects skin health markers and fibroblast activity in healthy adults aged 18–50.

  Recruiting University Hospital, Geneva · Geneva · NCT07542132

• 12-week nutrient supplement for skin appearance and overall well-being

  This study will test whether taking vitamin C & green tea plus a multivitamin/mineral supplement for 12 weeks helps improve skin appearance and perceived health in healthy Chinese adults who eat few fruits and vegetables.

  Recruiting ChinaNorm · Shanghai, Shanghai Municipality · NCT07383974

• Probiotic drink for skin inflammation during the menopausal transition

  This study will test whether a daily Lactobacillus casei Shirota probiotic drink can reduce inflammation and improve immune and skin health in women aged 40–60 going through the menopausal transition with inflammatory facial skin conditions.

  Recruiting King's College London · London, London · NCT07341087

• Fish oil omega-3-9-11 for improving skin function

  This trial will test whether taking EPAX Omega 3-9-11 fish oil capsules can reduce facial redness and improve skin barrier function in adults aged 35–65 with dry or atopy-prone skin.

  Recruiting Epax Norway AS · Cardiff · NCT07133477

• Dual treatment with KeraFactor and Revian LED for female pattern hair loss

  This study tests whether using a scalp-stimulating serum together with a Revian LED cap helps women with androgenic alopecia grow more hair than each treatment alone or placebo.

  Recruiting K. Kay Durairaj, MD, FACS, A Medical Corporation · Pasadena, California · NCT07810504

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.